Leukocytapheresis for the treatment of IBD
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Hepatology,General Medicine
Link
http://www.nature.com/articles/ncpgasthep1209.pdf
Reference64 articles.
1. Bjarnason I et al. (1993) Non-steroidal anti-inflammatory drugs and Crohn's disease. In Inflammatory Bowel Diseases: Pathophysiology as Basis of Treatment, 208–222 (Eds Scholmeric J) Falk Symposium No 67. Lancaster: Kluwer Academic Publishers
2. Tibble J et al. (2000) Surrogate markers of intestinal inflammation are predictive for relapse in patients with inflammatory bowel disease. Gastroenterology 119: 15–22
3. Kozuch PL and Hanauer SB (2008) Treatment of inflammatory bowel disease: a review of medical therapy. World J Gastroenterol 14: 354–377
4. Yamamoto-Furusho JK (2007) Innovative therapeutics for inflammatory bowel disease. World J Gastroenterol 13: 1893–1896
5. Brown SL et al. (2002) Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 46: 3151–3158
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Recent advances in microfluidic cell separation to enable centrifugationfree, low extracorporeal volume leukapheresis in pediatric patients;BLOOD TRANSFUS-ITALY;2023
2. A high-throughput microfluidic device based on controlled incremental filtration to enable centrifugation-free, low extracorporeal volume leukapheresis;Scientific Reports;2022-08-13
3. A Review of Hyperbaric Oxygen Therapy for Inflammatory Bowel Disease;International Journal of General Medicine;2021-10
4. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020;Journal of Gastroenterology;2021-04-22
5. Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study;Therapeutic Apheresis and Dialysis;2020-11-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3